Comparison of efficacy and safety of topical 0.1% tacrolimus ointment versus 0.1% mometasone furoate ointment in mild to moderate chronic hand eczema
Keywords:
Hand eczema, tacrolimus, mometasone furoate, physician global assessmentAbstract
Objectives To evaluate the therapeutic efficacy and safety of 0.1% tacrolimus ointment versus mometasone furoate 0.1% ointment in mild to moderate chronic hand eczema. Methods It was a randomized control trial carried out in dermatology department unit-II, KEMU/ Mayo Hospital, Lahore. Patients with mild to moderate chronic hand eczema were enrolled with age range between 18-70 years, of either sex. We randomized the patients in two groups A & B by balloting. Group A used tacrolimus 0.1% ointment twice daily for 6 weeks. Group B used mometasone furoate 0.1% ointment twice daily for 6 weeks. The data were collected and analyzed by SPSS version 18 and p-value <0.05 was taken as significant. Results The study was completed by 102 patients, with 51 in each group, with mean age of 32 years and majority were married females. Both the treatment options were found to be equally efficacious with PGA Score showing significant p value at the end of study (p-value = 0.042). The side effects noted were itching and irritation. Irritation was observed in both treatment groups but did not lead to discontinuation of the treatment as it was transient. This complaint was seen more among the Group A patients. Conclusion It is concluded from our study that 0.1% tacrolimus ointment and 0.1% mometasone furoate ointment are equally efficacious and safe in the treatment of mild to moderate chronic hand eczema.References
Castanedo-Tardan MP, Zug KA. Allergic contact dermatitis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, eds. Fitzpatrick’s Dermatology in General Medicine, 8th edn. New York; McGraw-Hill, 2012: p.152-64.
Berth-Jones J, Eczema, Lichenification, Prurigo and Erythroderma. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology, 8th edn. UK: Wiley-Blackwell Publications; 2010: p. 23.1-24.34.
Wilkinson SM, Beck MH. Contact dermatitis: Irritant. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology, 8th edn. UK: Wiley-Blackwell Publications; 2010: p. 25.1-25.26.
Robertson L. New and existing therapeutic options for hand eczema. Skin Ther Lett. 2009;14:1-5.
Bissonnette R, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzicka T et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol. 2010;162:420-6.
Diepgen TL, Pfarr E, Zimmermann T. Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients. Acta Derm Venereol. 2012;92:251-5.
Coenraads PJ. Hand eczema. N Engl J Med. 2012;367:1829-37.
Chaudhari ND, Talaniker HV, Gupta S, Gupta A, Deshmukh P, Rizvi A. Topical tacrolimus: A boon to dermatology. Int J Pharm Biomed Sci. 2012;3:188-92.
Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs Mometasone Furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22:192-6.
Rani Z, Kazmi AH, Raza A, Rashid A, Waseem J, Sheikh RA. Efficacy, safety and tolerability of mometasone furoate 0.1% ointment in chronic hand eczema. J Pak Assoc Dermatol. 2007;17:21-7.
Schnopp C, Remling R, Mohrenschlager M, Weigl L, Ring J, Abeck D. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: A randomized, observer-blinded trial. J Am Acad Dermatol. 2002;46:73-7.
Krejci-Manwaring J, McCarty MA, Camacho F, Manuel J, Hartle J, Fleischer A et al. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol. 2008;7:643-6.
Shri J, Amichal B. Tacrolimus ointment in the treatment of atopic hand eczema. Indian J Dermatol. 2006;51:66-7.
Schliemann S, Kelterer D, Bauer A, John SM, Skudlik C, Schindera I et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008;58:299-306.
Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (Protopic®) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis. 2003;49:185-8.
